Samuel Appiah

Samuel Appiah, PharmD, RPh, currently serves as a Senior Scientific Manager in Multiple Myeloma within U.S. Medical Affairs at Bristol Myers Squibb, a position held since June 2020. Prior roles at the same company include Pharmacovigilance Scientist and Pharmacovigilance Associate specializing in Cell Therapy. Previously, Samuel worked as a Healthcare Consultant for Restoring Hope Foundations and gained experience as an Analytical Chemist and Account Representative at Multi Chem Production Chmcls. Samuel holds a Doctor of Pharmacy from Lake Erie College of Osteopathic Medicine and a Bachelor of Science in Biology and Chemistry from Texas Southern University.